XOR activity in the liver has been reported to be higher in gouty patients with overproduction of uric acid [31], and XOR is a therapeutic target for the treatment of patients with hyperuricemia and gout caused by overproduction of uric acid [32]. The gene discussed is XDH; the disease is hyperuricemia.